Physician
Hematology
Dr. Howard J. Fingert, MD
Dr. Howard J. Fingert works in the field of Hematology. He went to University of Illinois College of Medicine. Howard J. Fingert is a published doctor. He published 31 publications, including: 'Cisplatin, cytosine arabinoside, and pentoxifylline in the treatment of squamous cell carcinoma of the head and neck.'
Publications
- Dose Selection for the Investigational Anticancer Agent Alisertib (MLN8237): Pharmacokinetics, Pharmacodynamics, and Exposure-Safety Relationships.
- Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: Phase 1 dose-escalation study.
- Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas.
- Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors.
- Cisplatin-vincristine-bleomycin therapy in squamous cell carcinoma of the head and neck.
- Cisplatin, cytosine arabinoside, and pentoxifylline in the treatment of squamous cell carcinoma of the head and neck.
- Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors.
- Baseline heart rate-corrected QT and eligibility for clinical trials in oncology.
- A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in...
- Consideration of QT/QTc interval data in a phase I study in patients with advanced cancer.
- Safety biomarkers and the clinical development of oncology therapeutics: considerations for cardiovascular safety and risk management.
- In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle.
- Performance characteristics of a multimedia system for clinical data management.
- The fluorescent cytoprint assay in gynecological malignancies and breast cancer. Methodology and results.
- Incapacitating autonomic neuropathy precipitated by taxol.
- Cyclin E, a potential prognostic marker for breast cancer.
- Transplantation of human or rodent tumors into cyclosporine-treated mice: a feasible model for studies of tumor biology and chemotherapy.
- Enhanced lethality by methylxanthines in human bladder cancer cells treated with thiotepa.
- Megadose chemotherapy with bone marrow rescue.
- Rapid growth of human cancer cells in a mouse model with fibrin clot subrenal capsule assay.
- In vivo and in vitro enhanced antitumor effects by pentoxifylline in human cancer cells treated with thiotepa.
- Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents.
- Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up.
- Implantation of human meningiomas into the subrenal capsule of the nude mouse. A model for studies of tumor growth.
- Predictive value of the fluorescent cytoprint assay (FCA): a retrospective correlation study of in vitro chemosensitivity and individual responses to chemotherapy.
- Assessing proarrhythmic potential of drugs when optimal studies are infeasible.
- Brain natriuretic peptide: potential adjunct for cardiac risk assessment and management during treatment with experimental anticancer agents.
- Drug-induced QTc interval prolongation: a proposal towards an efficient and safe anticancer drug development.
- Cardiac safety, risk management, and oncology drug development.
- Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961).
Schools
University of Illinois At Chicago College of Medicine
Cedars Sinai Med Center
Harvard University
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Massachusetts General Hospital
-
Cedars-Sinai Medical Center
-
University of Illinois College of Medicine
Helpful Reviews
Give
Anonymous Review
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog